A&O Shearman yields a dedicated life sciences team, with experience representing global pharmaceutical and biotech companies in matters spanning regulatory and intellectual property work. Peter Van Dyck leads the practice, specialising in intellectual property disputes related to the life sciences sector. Van Dyck acts as head of the team alongside Tine Carmeliet is skilled at aiding clients dealing with EU regulations linked to the development of new medical products. Eline D’Joos is another key contact.
Testimonials
Collated independently by Legal 500 research team.
‘As a global company pharmaceutical company operating in low and low middle income countries who rely on the European Medicines Agency for drug approvals, I need an outside counsel like A&O Shearman who is familiar with the procedures of the World Health Organization to approve drugs for LMICs.'